michael f. michelis, m.d., f.a.c.p., f.a.s.n. director, division of nephrology lenox hill hospital,...
TRANSCRIPT
![Page 1: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/1.jpg)
Michael F. Michelis, M.D., F.A.C.P., F.A.S.N.
Director, Division of Nephrology
Lenox Hill Hospital, New York
Clinical Professor of Medicine
New York University School of Medicine
ARGININE VASOPRESSIN (AVP)
AFFECTS BLOOD PRESSURE AND RENAL WATER REABSORPTION
WHAT ELSE DOES IT DO?
![Page 2: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/2.jpg)
AVP AND THE HYPOTHALAMO-PITUITARY SYSTEM
Koshimizu T et al. Physiol Rev 2012;92:1813-1864
![Page 3: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/3.jpg)
AVP MOLECULEAVP MOLECULE
![Page 4: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/4.jpg)
Regulate Vascular Tone
Regulate H2OReabsorption by the Kidney
AVP (ADH)
V1a Receptors V2 Receptors
![Page 5: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/5.jpg)
Regulation of AVP Secretion
Both increased plasma osmolality and decreased blood volume stimulate AVP secretion, but with different thresholds and sensitivities
Stricker et al. In: Fundamental Neuroscience. 2nd ed. 2003;1011-1029
-30 -30 -10 0 10 20
0
5
10
15
20
25
Pla
sma
Vas
op
ress
ion
(p
g/m
L)
Percent Change
Plasma osmolality
Basal
Blood pressure/volume
![Page 6: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/6.jpg)
Nonpressor and Nonantidiuretic Actions of Nonpressor and Nonantidiuretic Actions of VasopressinVasopressin
![Page 7: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/7.jpg)
Arginine Vasopressin Receptors and Arginine Vasopressin Receptors and Their LocationsTheir Locations
V1a Receptors
Smooth Muscle Cells
Brain
Adrenal Cortex
Adipose Tissue
Hepatocytes
Osteoblasts
Osteoclasts
![Page 8: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/8.jpg)
Arginine Vasopressin Receptors and Arginine Vasopressin Receptors and Their Locations Continued..Their Locations Continued..
V1b Receptors V2 Receptors
Anterior Pituitary Basolateral Membrane of Collecting Ducts
Adrenal Medulla Alveolar Epithelial Cells
Islet Cells of Langerhans
Osteoblasts
White Adipose Tissue
Osteoclasts
![Page 9: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/9.jpg)
AVP AND HEMOSTASISAVP AND HEMOSTASIS
DDAVP increases serum levels of vWF, DDAVP increases serum levels of vWF, factor 8 and t-PA via V2 receptors on renal factor 8 and t-PA via V2 receptors on renal and nonrenal epithelial cellsand nonrenal epithelial cells
Useful for treatment of Von Willebrand’s Useful for treatment of Von Willebrand’s disease and hemophiliadisease and hemophilia
![Page 10: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/10.jpg)
AVP AND PAIN PERCEPTIONAVP AND PAIN PERCEPTION
AVP exerts analgesic actionsAVP exerts analgesic actions
AVP can increase pain threshold when given AVP can increase pain threshold when given by intraventricular route (animal study)by intraventricular route (animal study)
Analgesic actions blocked by V1a receptor Analgesic actions blocked by V1a receptor antagonist. Intrathecal and intranasal AVP antagonist. Intrathecal and intranasal AVP also can reduce painalso can reduce pain
![Page 11: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/11.jpg)
AVP AND AGING, SOCIAL BEHAVIOR AVP AND AGING, SOCIAL BEHAVIOR AND COGNITIONAND COGNITION
Klotho increases resistance to oxidative Klotho increases resistance to oxidative stress (anti-aging), reduces 1,25 Vitamin D stress (anti-aging), reduces 1,25 Vitamin D (anti-hyperphosphatemia)(anti-hyperphosphatemia)
Klotho levels are reduced in dehydrated mice Klotho levels are reduced in dehydrated mice and in studies by high levels of AVPand in studies by high levels of AVP
AVP increases anxiety (V1a). Neuroleptic AVP increases anxiety (V1a). Neuroleptic drugs decrease AVP levels. Autism linked to drugs decrease AVP levels. Autism linked to mutation in V1a receptor genes.mutation in V1a receptor genes.
Dehydration affects cognitive function and Dehydration affects cognitive function and decreases in function are associated with decreases in function are associated with AVPAVP
![Page 12: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/12.jpg)
Ohnishi M et al. FASEB J 24: 3562-3571, 2010
![Page 13: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/13.jpg)
AVP AND BONEAVP AND BONE
AVP receptors V1a and V2 on osteoblasts AVP receptors V1a and V2 on osteoblasts and osteoclastsand osteoclasts
AVP stimulates osteoclasts and inhibits AVP stimulates osteoclasts and inhibits osteoblastsosteoblasts
Hyponatremia also activates osteoclasts and Hyponatremia also activates osteoclasts and limits defense against ROS by limiting limits defense against ROS by limiting movement of Vitamin C into cellsmovement of Vitamin C into cells
![Page 14: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/14.jpg)
Hyponatremia-Induced Osteoporosis
Verbalis JG et al. J Bone Miner Res 25(3): 554-563, 2010
Animal Study: Hyponatremia produced greater bone loss than aging alone after three months.
NHANES III: Data revealed hyponatremia was associated with increased odds of osteoporosis at the hip adjusted for age, sex, race, vitamin D25. (OR = 2.85, p<0.01)
![Page 15: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/15.jpg)
NORMONATREMIC
SOLID+DDAVP
HYPONATREMIC
LIQUID+DDAVP
Verbalis JG et al. J Bone Miner Res 25(3): 554-563, 2010
![Page 16: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/16.jpg)
AVP AND HYPOTHALAMIC PITUITARY AVP AND HYPOTHALAMIC PITUITARY AXISAXIS
HPA axis involves central CRH and AVP HPA axis involves central CRH and AVP (V1b) responses. V1b is more important in (V1b) responses. V1b is more important in stress situations.stress situations.
AVP also acts on receptors in adrenal gland AVP also acts on receptors in adrenal gland (V1a cortex and V1b medulla) for peripheral (V1a cortex and V1b medulla) for peripheral stress reactions.stress reactions.
![Page 17: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/17.jpg)
AVP AND INFLAMMATION AND AVP AND INFLAMMATION AND CELL PROLIFERATIONCELL PROLIFERATION
Inflammatory cytokines such as IL-6 and CRP Inflammatory cytokines such as IL-6 and CRP increase AVP levels (hyponatremia) and AVP increase AVP levels (hyponatremia) and AVP via V2 stimulation can reduce inflammation in via V2 stimulation can reduce inflammation in lungs by local decrease in IL-6lungs by local decrease in IL-6
Defective response of hypothalamus (CRH and Defective response of hypothalamus (CRH and AVP) decreases ACTH and thereby cortisol AVP) decreases ACTH and thereby cortisol response which fails to suppress inflammationresponse which fails to suppress inflammation
AVP increases cell proliferation in studies on AVP increases cell proliferation in studies on intestinal epithelial cells, renal mesangial cells intestinal epithelial cells, renal mesangial cells (V1a, VEGF) and blockade decreased lung (V1a, VEGF) and blockade decreased lung cancer cell growth cancer cell growth
![Page 18: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/18.jpg)
Chiu T et al. Am J Physiol Cell Physiol 282: C434–C450, 2002
![Page 19: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/19.jpg)
AVP AND INFECTIONAVP AND INFECTION
Response to infection involves innate Response to infection involves innate immunity, TLRs, and renal tubular epithelial immunity, TLRs, and renal tubular epithelial cells. TLR4 recognizes LPS on gram negative cells. TLR4 recognizes LPS on gram negative organisms and activates factors which organisms and activates factors which destroy the organism.destroy the organism.
DDAVP inhibits LPS induced activation of anti DDAVP inhibits LPS induced activation of anti gram negative organism factors. This can be gram negative organism factors. This can be prevented by V2 blockers.prevented by V2 blockers.
Dehydration and increased AVP may play a Dehydration and increased AVP may play a role in susceptibility to infection. role in susceptibility to infection.
![Page 20: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/20.jpg)
AVP AND METABOLIC SYNDROMEAVP AND METABOLIC SYNDROME
Metabolic Syndrome includes:Metabolic Syndrome includes:
• Insulin Resistance (DM)Insulin Resistance (DM)
• DyslipidemiaDyslipidemia
• HypertensionHypertension
• Obesity, Sleep Apnea, Fatty LiverObesity, Sleep Apnea, Fatty Liver
AVP actions include liver and pancreas effectsAVP actions include liver and pancreas effects
and ACTH secretion. and ACTH secretion.
![Page 21: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/21.jpg)
AVP AND DIABETIC MELLITUSAVP AND DIABETIC MELLITUS
V1a receptors on hepatocytes cause V1a receptors on hepatocytes cause glycolysis and V1b receptors are found on glycolysis and V1b receptors are found on pancreatic alpha cells (glucagon) and beta pancreatic alpha cells (glucagon) and beta cells (insulin) but V1b receptors on alpha cells (insulin) but V1b receptors on alpha cells are more sensitive to AVPcells are more sensitive to AVP
AVP also stimulates ACTH via V1b receptors AVP also stimulates ACTH via V1b receptors in the pituitary and V1a receptors in the in the pituitary and V1a receptors in the adrenal cortex to increase cortisol (glucose)adrenal cortex to increase cortisol (glucose)
![Page 22: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/22.jpg)
Cells, Receptors and the Effects of Arginine Vasopressin on the Blood
Glucose Levels
Hepatocytes V1a-Glycolysis
Beta islet cells V1b- Insulin release
Alpha islet cells V1b- Glucagon release
CNS (Pituitary) cells V1b- ACTH release increases glucocorticoids
Adrenal Cortex V1a- increases glucocorticoids
![Page 23: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/23.jpg)
AVP AND ACTH AND STRESSAVP AND ACTH AND STRESS
CRH and AVP cause ACTH to be released CRH and AVP cause ACTH to be released from pituitaryfrom pituitary
stress stress V1b V1b releases ACTH releases ACTH cortisol cortisol glucose glucose
ACTH released by AVP does not respond to ACTH released by AVP does not respond to negative feedback via cortisol as does CRH negative feedback via cortisol as does CRH induced ACTH releaseinduced ACTH release
![Page 24: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/24.jpg)
COPEPTIN AND AVPCOPEPTIN AND AVP
Copeptin surrogate marker of AVP as it is Copeptin surrogate marker of AVP as it is secreted with AVPsecreted with AVP
Easier to use as a marker since longer half Easier to use as a marker since longer half life, not attached to plateletslife, not attached to platelets
Higher levels correlate with Mets, increased Higher levels correlate with Mets, increased TG levels and predictor of obesity, TG levels and predictor of obesity, proteinuria, and DM (15+ years Swedish proteinuria, and DM (15+ years Swedish study)study)
![Page 25: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/25.jpg)
COPEPTIN AND SERUM OSMOLALITY
Fenske W K et al. JASN 2014;25:2376-2383
©2014 by American Society of Nephrology
![Page 26: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/26.jpg)
AVP AND LIPIDSAVP AND LIPIDS
AVP stimulates sympathetic nerve activity in the AVP stimulates sympathetic nerve activity in the CNS which can increase fatty acidsCNS which can increase fatty acids
AVP has an antilipolytic effect involving V1a AVP has an antilipolytic effect involving V1a receptors in adipose tissue. V1a regulates insulin receptors in adipose tissue. V1a regulates insulin mediated glucose uptake.mediated glucose uptake.
V1a deficient rodents demonstrate increased V1a deficient rodents demonstrate increased lipolysislipolysis
AVP stimulates glycogenolysis in liver increasing AVP stimulates glycogenolysis in liver increasing glucose and triglyceride levelsglucose and triglyceride levels
Blockade of V1b can suppress lipolysis and Blockade of V1b can suppress lipolysis and increase lipogenesis by increasing insulin increase lipogenesis by increasing insulin sensitivitysensitivity
![Page 27: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/27.jpg)
AVP AND HYPERTENSIONAVP AND HYPERTENSION
AVP deficiency contributes to vasodilation in AVP deficiency contributes to vasodilation in septic shockseptic shock
Studies over last 40 years have cited issues Studies over last 40 years have cited issues with sodium excretion (less efficient) in black with sodium excretion (less efficient) in black vs white subjectsvs white subjects
Bankir, Parucca and MH Weinberger 2007 Bankir, Parucca and MH Weinberger 2007 published a comprehensive study published a comprehensive study demonstrating more concentrated urine, demonstrating more concentrated urine, higher pulse pressure and delay in sodium higher pulse pressure and delay in sodium excretion in black individualsexcretion in black individuals
![Page 28: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/28.jpg)
Bankir, L et al. CJASN 2: 304-312, 2007
![Page 29: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/29.jpg)
AVP AND CKD PROGRESSIONAVP AND CKD PROGRESSION
Not only previously mentioned actions regarding Not only previously mentioned actions regarding diabetes mellitus and hypertension but also data diabetes mellitus and hypertension but also data relating low urine volumes and CKD progressionrelating low urine volumes and CKD progression
AVP stimulates the renin-angiotensin system via AVP stimulates the renin-angiotensin system via the V2 receptor. May decrease sodium excretion the V2 receptor. May decrease sodium excretion and cause hyperfiltrationand cause hyperfiltration
DDAVP infusion increases urine osmolality and DDAVP infusion increases urine osmolality and increases UAE. AVP infusion increases GFR increases UAE. AVP infusion increases GFR with increased urine concentration and with increased urine concentration and decreased FENAdecreased FENA
Efffects can be altered by ACE and V2 blockadeEfffects can be altered by ACE and V2 blockade
![Page 30: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/30.jpg)
Meijer, E. et al. Kidney Int. 77: 29-36, 2010
![Page 31: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/31.jpg)
Bankir, L. et al. Nat. Rev. Nephrol 9: 223-239, 2013
![Page 32: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/32.jpg)
Bardoux P et al. NDT 18:1755-1763, 2003
![Page 33: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/33.jpg)
IN SUMMARYIN SUMMARY
Arginine vasopressin exerts a variety of Arginine vasopressin exerts a variety of actions on multiple functions such as pain actions on multiple functions such as pain perception, behavior and cognitionperception, behavior and cognition
Integrity of bone, inflammatory reactions, cell Integrity of bone, inflammatory reactions, cell proliferation, and responses to infection and proliferation, and responses to infection and stress are also influenced by AVPstress are also influenced by AVP
Actions of AVP related to metabolic syndrome Actions of AVP related to metabolic syndrome involving glucose, lipids and blood pressure involving glucose, lipids and blood pressure and effects relating to hydration status, and effects relating to hydration status, hyperfiltration and proteinuria may influence hyperfiltration and proteinuria may influence the progression of chronic kidney diseasethe progression of chronic kidney disease
![Page 34: Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital, New York Clinical Professor of Medicine New York University](https://reader035.vdocuments.us/reader035/viewer/2022062315/5697bfa01a28abf838c9569e/html5/thumbnails/34.jpg)
THANK YOU YOU